Gilead Sciences
GILD----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Gilead Sciences(GILD) predict that the Revenue is 6.96 B (+4.39%), Beat estimate;the EBIT is 3.267 B (+12.93%), Beat estimate;the EPS is 1.61 (+54.81%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
6.96B4.39%
6.94B4.06%
+0.02B0.33%
EBITExceed expectations
3.27B12.93%
3.09B6.92%
+0.17B6.01%
EPSExceed expectations
1.6154.81%
1.580551.98%
+0.02952.83%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateAug 4, 2026
Estimate Revenue7.397 B
Estimate EBIT-8.04 B
Estimate EPS-7.7602
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf